Nanogroup SA (NNG) - Total Liabilities
Based on the latest financial reports, Nanogroup SA (NNG) has total liabilities worth zł5.26 Million PLN (≈ $1.45 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Nanogroup SA to evaluate the company's liquid asset resilience ratio.
Nanogroup SA - Total Liabilities Trend (2014–2024)
This chart illustrates how Nanogroup SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Nanogroup SA balance sheet assets.
Nanogroup SA Competitors by Total Liabilities
The table below lists competitors of Nanogroup SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kidoz Inc
V:KIDZ
|
Canada | CA$2.19 Million |
|
DE&T Co. Ltd
KQ:079810
|
Korea | ₩54.22 Billion |
|
Turk Ilac ve Serum Sanayi AS
IS:TRILC
|
Turkey | TL4.21 Billion |
|
Quickfee Ltd
AU:QFE
|
Australia | AU$68.83 Million |
|
HiTi Digital Inc
TW:3494
|
Taiwan | NT$1.18 Billion |
|
Cubic Korea Inc
KQ:021650
|
Korea | ₩71.44 Billion |
|
Fun Yours Technology Co Ltd
TWO:6482
|
Taiwan | NT$153.98 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Nanogroup SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See NNG equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nanogroup SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nanogroup SA (2014–2024)
The table below shows the annual total liabilities of Nanogroup SA from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | zł4.01 Million ≈ $1.10 Million |
+15.45% |
| 2023-12-31 | zł3.47 Million ≈ $955.64K |
-69.58% |
| 2022-12-31 | zł11.42 Million ≈ $3.14 Million |
-4.36% |
| 2021-12-31 | zł11.94 Million ≈ $3.29 Million |
+5.91% |
| 2020-12-31 | zł11.27 Million ≈ $3.10 Million |
-13.75% |
| 2019-12-31 | zł13.07 Million ≈ $3.60 Million |
+13.52% |
| 2018-12-31 | zł11.51 Million ≈ $3.17 Million |
+36.42% |
| 2017-12-31 | zł8.44 Million ≈ $2.32 Million |
+25.86% |
| 2016-12-31 | zł6.70 Million ≈ $1.85 Million |
+1227.13% |
| 2015-12-31 | zł505.16K ≈ $139.03K |
-64.92% |
| 2014-12-31 | zł1.44 Million ≈ $396.29K |
-- |
About Nanogroup SA
NanoGroup S.A. operates as a biotechnology company in Poland. The company develops and licenses early-stage pre-clinical and IND solutions to international biotech and pharma companies. It also manages a portfolio of companies that manages projects for the need of modern medicine in the field of oncology and transplantology. The company was incorporated in 2016 and is based in Warsaw, Poland.